mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.

MRNA Vaccines: "The University of Sheffield's versatile RNAbox builds on the 'vaccine revolution' experienced during the ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Pfizer and BioNTech successfully invalidated two CureVac patents at London's High Court. The lawsuit filed in September 2022 ...

Messenger RNA (mRNA) serves as a blueprint for proteins. When mRNA is no longer needed, it must be degraded. Director Elena ...

THE Nobel Prize in Physiology-Medicine has been awarded to two scientists for their discovery of micro-RNA (mRNA), which ...

The most recent trading session ended with Moderna (MRNA) standing at $57.73, reflecting a -0.96% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.77%.

Germany, Norway, Luxembourg, Denmark, and Ireland made the biggest new commitments to WHO funding. View on euronews ...

Both Moderna and Pfizer made history during the COVID-19 pandemic thanks to mRNA technology. Now, Moderna and Pfizer embarked on a journey to treat cancer with mRNA science. By using mRNA-based ...